Know when to travel for cancer treatment. And when not to.
CancerCareE is an independent knowledge and comparison platform for advanced cancer treatments. We explain the therapies in plain language, compare what is available across countries, and help you ask the right questions — before you spend money or travel.
Where CAR-T Is Available
A comparison of CAR-T availability across seven destinations. Statuses describe regulatory and access conditions — not medical advice.
| Country | Status | Typical duration | Visa | Practical note |
|---|---|---|---|---|
| United States | Approved | 6–12 weeks | B-2 (tourist/medical) | Latest approvals; very high out-of-pocket cost. |
| Germany | Approved | 4–8 weeks | Schengen | High clinical standards; long waits for non-urgent reviews. |
| China | Approved | 4–8 weeks | Medical visa (varies by hospital) | Active research; language support varies by hospital. |
| India | Approved | 4–8 weeks | Medical visa | Lower cost; quality varies widely between hospitals. |
| South Korea | Approved | 4–8 weeks | Medical visa | High standards; limited English-language navigation. |
| Singapore | Approved | 4–8 weeks | Medical visa | High cost; strong English-language support. |
| Turkey | Approved | 3–6 weeks | Depends on nationality | Shorter travel; hospital variability — verify the specific centre. |
Last reviewed: 2026-10-29. Statuses describe regulatory and access conditions, not medical advice. Always confirm with the treating hospital and your oncologist.
Where Are You Right Now?
Three starting points. Pick the one that fits — you can always come back and choose another.
I was just diagnosed
I don't yet know what my options are, or how to read my pathology report.
Start with diagnosis & staging →My first treatment didn't work
I need to understand what other options exist, and how they compare.
Compare treatment options →I'm considering treatment abroad
I want to know whether travel makes sense for my case — before spending money.
Take the check above →Two Comparisons That Matter Most
Evidence-based comparisons to help you understand your options before any decision.
China vs USA in Cellular Therapy
Cost, wait times, clinical trial access, and quality of care — a side-by-side comparison of the two most-discussed destinations.
Read the comparison →CAR-T vs Chemotherapy
When advanced cell therapy is appropriate, how it compares with standard chemotherapy, and what the trade-offs look like.
Read the comparison →The 20-question checklist for your oncologist
Print it, or bring it to your next consultation. Available in five languages as a single-page PDF — free, no signup.
From Our Knowledge Base
Plain-language reading on new cancer therapies and where they are available.
Understanding CAR-T Cell Therapy: Who Qualifies?
A plain-language breakdown of eligibility criteria.
CAR-T therapy cost by country
How cost varies between the USA, China, India, Turkey, and Europe.
Cancer Staging Systems, Explained Simply
How stage is determined and why it matters for treatment choice.
BCLC 2025 Update: What Changed for Liver Cancer
The 2025 staging update, the CUSE framework, and treatment implications.
Glioblastoma Trials in China
Active trials and what international patients should know before applying.
From Our Founder
I built CancerCareE so that patients and families can see a clear picture of their options before any decision — without pressure, without promises, and with information they can review together with their oncologist. That is why we compare more than one destination, and why we say "don't go" when travel is not the right next step.
— Reza Abdollahi, Founder, CancerCareEFrequently Asked Questions
Common questions about our platform.
What is CancerCareE?
Who is this platform for?
Do you provide medical advice?
How do you compare countries?
Can you guarantee treatment outcomes?
How current is your information?
How can I use this platform?
Start With the Three-Question Check
It takes a minute and tells you what to do first — before you spend money or travel.